Somatic mutation signatures in primary liver tumors of workers exposed to ionizing radiation.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
03 12 2019
Historique:
received: 19 09 2018
accepted: 18 11 2019
entrez: 5 12 2019
pubmed: 5 12 2019
medline: 11 11 2020
Statut: epublish

Résumé

Liver cancer is associated with genetic mutations caused by environmental exposures, including occupational exposure to alpha radiation emitted by plutonium. We used whole exome sequencing (WES) to characterize somatic mutations in 3 histologically distinct primary liver tumors (angiosarcoma of the liver (ASL), cholangiocarcinoma (CCA) and hepatocellular carcinoma (HCC)) from Mayak worker subjects occupationally exposed to ionizing radiation (IR) to investigate the contribution of IR to the mutational landscape of liver cancer. DNA sequence analysis revealed these tumors harbor an excess of deletions, with a deletions:substitutions ratio similar to that previously reported in radiation-associated tumors. These tumors were also enriched for clustered mutations, a signature of radiation exposure. Multiple tumors displayed similarities in abrogated gene pathways including actin cytoskeletal signaling and DNA double-strand break (DSB) repair. WES identified novel candidate driver genes in ASL involved in angiogenesis and PIK3CA/AKT/mTOR signaling. We confirmed known driver genes of CCA, and identified candidate driver genes involved in chromatin remodeling. In HCC tumors we validated known driver genes, and identified novel putative driver genes involved in Wnt/β-catenin signaling, chromatin remodeling, PIK3CA/AKT/mTOR signaling, and angiogenesis. This pilot study identifies several novel candidate driver mutations that are likely to be caused by IR exposure, and provides the first data on the mutational landscape of liver cancer after IR exposure.

Identifiants

pubmed: 31796844
doi: 10.1038/s41598-019-54773-z
pii: 10.1038/s41598-019-54773-z
pmc: PMC6890664
doi:

Substances chimiques

Radioactive Waste 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

18199

Subventions

Organisme : U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
ID : P30-CA051008
Pays : International

Références

Nat Commun. 2015 Mar 26;6:6684
pubmed: 25809527
BMC Med Genomics. 2011 Sep 29;4:68
pubmed: 21958464
Bioinformatics. 2015 Nov 15;31(22):3673-5
pubmed: 26163694
Radiat Res. 2000 Sep;154(3):237-45
pubmed: 10956428
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Science. 2011 Jan 28;331(6016):435-9
pubmed: 21163964
Health Phys. 2013 Aug;105(2):165-76
pubmed: 23799501
Curr Protoc Bioinformatics. 2013;43:11.10.1-11.10.33
pubmed: 25431634
Hepatology. 2013 Nov;58(5):1693-702
pubmed: 23728943
Nat Genet. 2015 Sep;47(9):1003-10
pubmed: 26258846
Nat Genet. 2013 Dec;45(12):1474-8
pubmed: 24185513
Nature. 2013 Jul 11;499(7457):214-218
pubmed: 23770567
Clin Liver Dis. 2008 Feb;12(1):131-50, ix
pubmed: 18242501
Ann ICRP. 2007;37(2-4):1-332
pubmed: 18082557
J Am Coll Surg. 2002 Nov;195(5):713-8
pubmed: 12437262
Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19855-60
pubmed: 18077418
Cell Rep. 2015 Sep 22;12(11):1915-26
pubmed: 26344771
BMC Cancer. 2016 Aug 30;16:692
pubmed: 27578032
Future Oncol. 2013 Feb;9(2):219-33
pubmed: 23414472
Ann Surg Oncol. 2014 Nov;21(12):3827-34
pubmed: 24889489
Nat Biotechnol. 2013 Mar;31(3):213-9
pubmed: 23396013
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Radiat Res. 2007 Dec;168(6):639-49
pubmed: 18088181
Genome Biol. 2016 Jun 06;17(1):122
pubmed: 27268795
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Nat Genet. 2011 Aug 07;43(9):828-9
pubmed: 21822264
Nat Genet. 2014 Dec;46(12):1267-73
pubmed: 25362482
Nat Genet. 2013 Dec;45(12):1470-1473
pubmed: 24185509
Nat Genet. 2012 May 06;44(6):690-3
pubmed: 22561520
Radiat Prot Dosimetry. 2017 Apr 1;173(1-3):10-15
pubmed: 27884938
Radiat Res. 1998 Apr;149(4):366-71
pubmed: 9525501
PLoS One. 2015 Dec 07;10(12):e0144162
pubmed: 26641479
Nat Genet. 2014 Apr;46(4):376-379
pubmed: 24633157
Radiat Res. 2010 Dec;174(6):816-24
pubmed: 21128806
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Gut. 2012 Dec;61(12):1657-69
pubmed: 22895392
Cancer Cell. 2017 Jul 10;32(1):57-70.e3
pubmed: 28648284
Oncologist. 2014 Mar;19(3):235-42
pubmed: 24563076
Cancer Res. 2001 May 15;61(10):3894-901
pubmed: 11358802
Oncogene. 2015 Apr 23;34(17):2215-26
pubmed: 24909175
Sci Rep. 2014 Dec 05;4:7330
pubmed: 25476455
Front Genet. 2013 Mar 25;4:37
pubmed: 23532176
Cancer Discov. 2017 Oct;7(10):1116-1135
pubmed: 28667006
Br J Haematol. 2012 Jan;156(1):76-88
pubmed: 22050763
Health Phys. 2013 Apr;104(4):366-78
pubmed: 23439140
Br J Ind Med. 1980 Aug;37(3):213-21
pubmed: 7191719
Radiat Res. 2000 Sep;154(3):246-52
pubmed: 10956429
Nat Rev Cancer. 2003 Mar;3(3):155-68
pubmed: 12612651
Genome Res. 2013 Sep;23(9):1422-33
pubmed: 23788652
Hepatology. 2014 Dec;60(6):1972-82
pubmed: 24798001
Nat Genet. 2012 Oct;44(10):1075-7
pubmed: 23011223
Nucleic Acids Res. 2017 Jan 4;45(D1):D777-D783
pubmed: 27899578
Nat Commun. 2016 Sep 12;7:12605
pubmed: 27615322
Nat Genet. 2015 May;47(5):505-511
pubmed: 25822088
Int J Cancer. 2008 Aug 15;123(4):905-11
pubmed: 18528867
Mol Cell. 2002 Feb;9(2):387-99
pubmed: 11864611
Genome Res. 2012 Mar;22(3):568-76
pubmed: 22300766
Genome Biol. 2014 Aug 26;15(8):436
pubmed: 25159915
J Clin Oncol. 2006 Jan 20;24(3):361-9
pubmed: 16421417
Genes Dev. 2001 Sep 1;15(17):2177-96
pubmed: 11544175
Radiat Res. 2013 Jul;180(1):100-9
pubmed: 23682596
World J Surg Oncol. 2012 Jan 26;10:23
pubmed: 22280556
PLoS One. 2014 Dec 23;9(12):e115383
pubmed: 25536104
Nat Protoc. 2009;4(7):1073-81
pubmed: 19561590
Radiother Oncol. 2011 Oct;101(1):13-7
pubmed: 21726915
Mol Biol Cell. 2000 Sep;11(9):2885-900
pubmed: 10982388
J Biol Chem. 2015 Jan 30;290(5):2744-58
pubmed: 25512383

Auteurs

David S Goerlitz (DS)

Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.

Jan Blancato (J)

Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.

Archana Ramesh (A)

Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.

Md Islam (M)

Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.

Garrett T Graham (GT)

Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.

Valentina Revina (V)

Russian Radiobiology Human Tissue Repository, Southern Urals Biophysics Institute, Ozyorsk, Chelyabinsk Oblast, Russian Federation.

Bhaskar Kallakury (B)

Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.

Jay Zeck (J)

Department of Pathology, Georgetown University, Washington, District of Columbia, USA.

Evgeniya Kirillova (E)

Russian Radiobiology Human Tissue Repository, Southern Urals Biophysics Institute, Ozyorsk, Chelyabinsk Oblast, Russian Federation.

Christopher A Loffredo (CA)

Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA. cal9@georgetown.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH